class action lawsuit semaglutide Ozempic Stomach Paralysis Lawsuits Class Action Lawsuit Challenges Noncoverage

PMID:40074721

Nutrients, 16 (7), 963

These findings are helping to shift public and institutional views, signaling that weight loss medications play a legitimate role in treating serious health issues

doi: 10.1210/clinem/dgab722 63 WilsonJMLinYLuoMJConsidineGCoxALBowsmanLMet al

EU approval typically follows FDA approval by 36 months

Separate studies delved directly into the brain to look for tell-tale signs with bi-polar: Postmortem studies of patients with BD revealed reduced expression of NMDAR subunit NR1 in the prefrontal cortex (44) and reduced expression of several NMDA, AMPA, and kainite receptor subunits in the medial temporal cortex Again, pointing to reduced glutamate at the NMDA receptor